The use of platelet rich plasma in the management of medication-related osteonecrosis of the jaws: a cohort study

Medication-related osteonecrosis of the jaw (MRONJ) is an adverse drug reaction that occurs in a very different ways and affects patients with complex medical histories. The objective this study to evaluate prognosis surgically treated drug-related osteonecrotic lesions verify whether platelet concentrates used during surgical procedure can improve prognosis.The was performed by analyzing sample 64 medication-related maxillary bones, which 79 were diagnosed at S. Orsola-Malpighi Polyclinic Bologna. The PRP showed lower tendency relapse compared its non-use, probability recurrence. In conclusion, demonstrates treatment may have positive effects therapy Medication-Related Osteonecrosis Jaw (MRONJ).